Interestingly, CBFA2T3-GLIS2 AML presents with a peculiar “RAM” immunophenotype characterized by high CD56 (NCAM) expression and low or no expression of HLA-DR, CD45 and CD38 antigens. This evidence concerns the gene NCAM1 and acute myeloid leukemia.